更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
龙沙集团2025年第三季度业绩强劲,并确认其CDMO与CHI业务全年展望——TradingView
Lonza Delivers a Strong Q3 2025 and Confirms Full-Year 2025 Outlook for its CDMO and CHI Businesses TradingView
Lonza CHI获得NutraStrong胶原蛋白认证——营养视野网报道
Lonza CHI receives NutraStrong Collagen Verified certification nutritioninsight.com
确保营养保健品经久不衰:龙沙CHI谈生物利用度与感官吸引力 - 营养洞察网
Future-proofing nutraceuticals: Lonza CHI on bioavailability and sensory appeal nutritioninsight.com
龙沙任命安德烈亚斯·博雷尔为首席法律与公司事务官——合同制药
Lonza Appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer Contract Pharma
龙沙CHI创新战略内幕:面向未来的复杂药物胶囊技术 - 制药科技网
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs PharmTech.com
与龙沙胶囊与健康成分的同步进展——《营养展望》
Catching up with Lonza Capsules and Health Ingredients Nutritional Outlook
CDMO企业药明生物收购龙沙在华生物制药厂,加速布局亚太市场——Fierce Pharma报道
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market Fierce Pharma
JPM 2025:龙沙集团分享CHI退出与收购战略展望——聚焦制药技术领域
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy Pharmaceutical Technology
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页